Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), by Route of Administration (Injectable Anticoagulant and Oral Anticoagulant), and by Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global anticoagulants market expected to generate around USD 43.6 billion by 2025, at a CAGR of around 7.7% between 2019 and 2025. Anticoagulants reduce or prevent blood coagulation and delay clotting time. Anticoagulants are prescribed to people who are at a higher risk of developing blood clots.

15-Mar-2019 | Number of pages: 110 | Report Code: ZMR-3920 | Report Format : | Status : Published

Analysis

Anticoagulant medicines help in preventing blood clots and are prescribed to people who are at a higher risk of getting clots. Anticoagulant decreases their probabilities of developing severe conditions like heart attacks and strokes. Anticoagulants interrupt the process of blood clot formation, which are also referred to as blood-thinning medicines. If a blood clot restricts the movement of blood over a blood vessel, the afflicted part will cease to work properly. Clot formation could lead to serious medical conditions, such as strokes, deep vein thrombosis (DVT), heart attacks, and pulmonary embolism (PE). The most popular types of anticoagulants are novel oral anticoagulants (NOACs), Vitamin K antagonist, and Low-molecular-weight heparin (LMWH). Novel oral anticoagulants (NOACs) have gained immense popularity in recent years due to their multiple benefits. Vitamin K antagonists are prescribed for prolonged anticoagulation therapy. Low-molecular-weight heparin (LMWH) enables outpatient management of disorders, such as pulmonary embolism, deep vein thrombosis, etc.

The growing incidences of cardiovascular disorders, chronic diseases, and venous thromboembolism (VTE), increasing acceptance of novel oral anticoagulants (NOACs), growing awareness regarding the use of NOACs, escalating aging population, dearth of precise substitutes for anticoagulant drugs, advantageous government policies, and rising number of obese people will act as major driving factors of the global anticoagulants market. Increasing investments made by leading market players for developing novel products and offer solutions for high unmet patient needs will create new growth opportunities for the market players in the anticoagulants market. Nevertheless, the high cost of NOACs, the existence of alternative drugs, stringent government regulations, side-effect risks, and complications related to the use of oral anticoagulants may restrict the global anticoagulants market.

Global Anticoagulants Market

The global anticoagulants market is segmented based on drug class, route of administration, and application. By drug class, the anticoagulants market is segmented into NOACs, heparin and LMWH, vitamin K antagonist, and others. The NOACs is sub-segmented into bevyxxa, eliquis, lixiana and savaysa, pradaxa, and xarelto. The route of administration segment is divided into injectable anticoagulant and oral anticoagulant. The application segment is segmented into the stroke, atrial fibrillation, pulmonary embolism (PE), deep vein thrombosis (DVT), and others.

By region, North America will lead the global anticoagulants market over the forecast time period, owing to the presence of state-of-the-art healthcare setup, high demand for innovative therapeutics, huge target population, existence of trained healthcare professionals, and rising incidences of cardiovascular disorders. Europe will be the second largest market for anticoagulants in the years ahead, due to the escalating aging population, rising occurrences of chronic diseases, advantageous government policies, and the rising number of obese people. The Asia Pacific will propagate at a speedy rate over the forecast time period, owing to the huge population, growing number of people suffering from chronic disorders, such as cancer, diabetes, and cardiovascular diseases, promising government policies, and growing investments made by pharmaceutical companies for research and development.

Some players of the global anticoagulants market are Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals, Inc., among others.


Related Reports

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Neuromonitoring devices, Respiratory monitoring devices, Anesthesia monitor, Hemodynamic monitoring devices, Fetal and neonatal monitoring, Multiparameter monitoring devices and Others), by Type (Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, and Others), and End use (Hospitals, Ambulatory surgical centers, Homecare settings, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5368 | Report Format:

The report covers forecast and analysis for the Patient Monitoring Devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Patient Mon...Read More

COVID-19 Drug Delivery Devices Market by Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), by Route of Administration (Parenteral, Nasal, and Dermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5367 | Report Format:

The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-1...Read More

Face Shield Market by Material (Cellulose Acetate, Polycarbonate, and Others), and End-User (Oil & Gas, Construction, Healthcare, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5366 | Report Format:

The report covers forecast and analysis for the face shield market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the face shield market along w...Read More

Medical Protective Goggles Market by Type (Reusable Protective Goggles and Disposable Protective Goggles), and End-User (Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5365 | Report Format:

The report covers forecast and analysis for the medical protective goggles market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the medical pro...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.